非ホジキンリンパ腫（NHL）の世界市場（～2026年）

• 英文タイトル：Global Non Hodgkin Lymphoma (NHL) Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY03993
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は非ホジキンリンパ腫（NHL）のグローバル市場について調査・分析したレポートです。種類別（標準型、優秀型）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別非ホジキンリンパ腫（NHL）の競争状況、市場シェア
・世界の非ホジキンリンパ腫（NHL）市場：種類別市場規模 2015年-2020年（標準型、優秀型）
・世界の非ホジキンリンパ腫（NHL）市場：種類別市場規模予測 2021年-2026年（標準型、優秀型）
・世界の非ホジキンリンパ腫（NHL）市場：用途別市場規模 2015年-2020年（病院、クリニック）
・世界の非ホジキンリンパ腫（NHL）市場：用途別市場規模予測 2021年-2026年（病院、クリニック）
・北米の非ホジキンリンパ腫（NHL）市場分析：米国、カナダ
・ヨーロッパの非ホジキンリンパ腫（NHL）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの非ホジキンリンパ腫（NHL）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の非ホジキンリンパ腫（NHL）市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの非ホジキンリンパ腫（NHL）市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：F. Hoffmann-La Roche、Johnson & Johnson、Merck、Bristol Myers Squibb、Celgene、Eli Lilly、GlaxoSmithKline、Bayer
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver.

Market Analysis and Insights: Global Non Hodgkin Lymphoma (NHL) Market
The global Non Hodgkin Lymphoma (NHL) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Non Hodgkin Lymphoma (NHL) Scope and Market Size
Non Hodgkin Lymphoma (NHL) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non Hodgkin Lymphoma (NHL) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
F. Hoffmann-La Roche
Johnson & Johnson
Merck
Bristol Myers Squibb
Celgene
Eli Lilly
GlaxoSmithKline
Bayer

Market segment by Type, the product can be split into
Standard
Exellent
Market segment by Application, split into
Hosptial
Clinic

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Non Hodgkin Lymphoma (NHL) Revenue
1.4 Market by Type
1.4.1 Global Non Hodgkin Lymphoma (NHL) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Standard
1.4.3 Exellent
1.5 Market by Application
1.5.1 Global Non Hodgkin Lymphoma (NHL) Market Share by Application: 2020 VS 2026
1.5.2 Hosptial
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Non Hodgkin Lymphoma (NHL) Market Perspective (2015-2026)
2.2 Global Non Hodgkin Lymphoma (NHL) Growth Trends by Regions
2.2.1 Non Hodgkin Lymphoma (NHL) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non Hodgkin Lymphoma (NHL) Historic Market Share by Regions (2015-2020)
2.2.3 Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Non Hodgkin Lymphoma (NHL) Market Growth Strategy
2.3.6 Primary Interviews with Key Non Hodgkin Lymphoma (NHL) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Non Hodgkin Lymphoma (NHL) Players by Market Size
3.1.1 Global Top Non Hodgkin Lymphoma (NHL) Players by Revenue (2015-2020)
3.1.2 Global Non Hodgkin Lymphoma (NHL) Revenue Market Share by Players (2015-2020)
3.1.3 Global Non Hodgkin Lymphoma (NHL) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Non Hodgkin Lymphoma (NHL) Market Concentration Ratio
3.2.1 Global Non Hodgkin Lymphoma (NHL) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Non Hodgkin Lymphoma (NHL) Revenue in 2019
3.3 Non Hodgkin Lymphoma (NHL) Key Players Head office and Area Served
3.4 Key Players Non Hodgkin Lymphoma (NHL) Product Solution and Service
3.5 Date of Enter into Non Hodgkin Lymphoma (NHL) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Non Hodgkin Lymphoma (NHL) Historic Market Size by Type (2015-2020)
4.2 Global Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020)
5.2 Global Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Non Hodgkin Lymphoma (NHL) Market Size (2015-2020)
6.2 Non Hodgkin Lymphoma (NHL) Key Players in North America (2019-2020)
6.3 North America Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020)
6.4 North America Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020)

7 Europe
7.1 Europe Non Hodgkin Lymphoma (NHL) Market Size (2015-2020)
7.2 Non Hodgkin Lymphoma (NHL) Key Players in Europe (2019-2020)
7.3 Europe Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020)
7.4 Europe Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020)

8 China
8.1 China Non Hodgkin Lymphoma (NHL) Market Size (2015-2020)
8.2 Non Hodgkin Lymphoma (NHL) Key Players in China (2019-2020)
8.3 China Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020)
8.4 China Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020)

9 Japan
9.1 Japan Non Hodgkin Lymphoma (NHL) Market Size (2015-2020)
9.2 Non Hodgkin Lymphoma (NHL) Key Players in Japan (2019-2020)
9.3 Japan Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020)
9.4 Japan Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size (2015-2020)
10.2 Non Hodgkin Lymphoma (NHL) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020)
10.4 Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020)

11 India
11.1 India Non Hodgkin Lymphoma (NHL) Market Size (2015-2020)
11.2 Non Hodgkin Lymphoma (NHL) Key Players in India (2019-2020)
11.3 India Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020)
11.4 India Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Non Hodgkin Lymphoma (NHL) Market Size (2015-2020)
12.2 Non Hodgkin Lymphoma (NHL) Key Players in Central & South America (2019-2020)
12.3 Central & South America Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020)
12.4 Central & South America Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 F. Hoffmann-La Roche
13.1.1 F. Hoffmann-La Roche Company Details
13.1.2 F. Hoffmann-La Roche Business Overview
13.1.3 F. Hoffmann-La Roche Non Hodgkin Lymphoma (NHL) Introduction
13.1.4 F. Hoffmann-La Roche Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020))
13.1.5 F. Hoffmann-La Roche Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Non Hodgkin Lymphoma (NHL) Introduction
13.2.4 Johnson & Johnson Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Non Hodgkin Lymphoma (NHL) Introduction
13.3.4 Merck Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Bristol Myers Squibb
13.4.1 Bristol Myers Squibb Company Details
13.4.2 Bristol Myers Squibb Business Overview
13.4.3 Bristol Myers Squibb Non Hodgkin Lymphoma (NHL) Introduction
13.4.4 Bristol Myers Squibb Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020)
13.4.5 Bristol Myers Squibb Recent Development
13.5 Celgene
13.5.1 Celgene Company Details
13.5.2 Celgene Business Overview
13.5.3 Celgene Non Hodgkin Lymphoma (NHL) Introduction
13.5.4 Celgene Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020)
13.5.5 Celgene Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Non Hodgkin Lymphoma (NHL) Introduction
13.6.4 Eli Lilly Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Details
13.7.2 GlaxoSmithKline Business Overview
13.7.3 GlaxoSmithKline Non Hodgkin Lymphoma (NHL) Introduction
13.7.4 GlaxoSmithKline Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020)
13.7.5 GlaxoSmithKline Recent Development
13.8 Bayer
13.8.1 Bayer Company Details
13.8.2 Bayer Business Overview
13.8.3 Bayer Non Hodgkin Lymphoma (NHL) Introduction
13.8.4 Bayer Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020)
13.8.5 Bayer Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Non Hodgkin Lymphoma (NHL) Key Market Segments
Table 2. Key Players Covered: Ranking by Non Hodgkin Lymphoma (NHL) Revenue
Table 3. Ranking of Global Top Non Hodgkin Lymphoma (NHL) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Non Hodgkin Lymphoma (NHL) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Standard
Table 6. Key Players of Exellent
Table 7. Global Non Hodgkin Lymphoma (NHL) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Non Hodgkin Lymphoma (NHL) Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Non Hodgkin Lymphoma (NHL) Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Non Hodgkin Lymphoma (NHL) Market Share by Regions (2015-2020)
Table 11. Global Non Hodgkin Lymphoma (NHL) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Non Hodgkin Lymphoma (NHL) Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Non Hodgkin Lymphoma (NHL) Market Growth Strategy
Table 17. Main Points Interviewed from Key Non Hodgkin Lymphoma (NHL) Players
Table 18. Global Non Hodgkin Lymphoma (NHL) Revenue by Players (2015-2020) (Million US$)
Table 19. Global Non Hodgkin Lymphoma (NHL) Market Share by Players (2015-2020)
Table 20. Global Top Non Hodgkin Lymphoma (NHL) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Hodgkin Lymphoma (NHL) as of 2019)
Table 21. Global Non Hodgkin Lymphoma (NHL) by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non Hodgkin Lymphoma (NHL) Product Solution and Service
Table 24. Date of Enter into Non Hodgkin Lymphoma (NHL) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020) (Million US$)
Table 27. Global Non Hodgkin Lymphoma (NHL) Market Size Share by Type (2015-2020)
Table 28. Global Non Hodgkin Lymphoma (NHL) Revenue Market Share by Type (2021-2026)
Table 29. Global Non Hodgkin Lymphoma (NHL) Market Size Share by Application (2015-2020)
Table 30. Global Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020) (Million US$)
Table 31. Global Non Hodgkin Lymphoma (NHL) Market Size Share by Application (2021-2026)
Table 32. North America Key Players Non Hodgkin Lymphoma (NHL) Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Non Hodgkin Lymphoma (NHL) Market Share (2019-2020)
Table 34. North America Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020) (Million US$)
Table 35. North America Non Hodgkin Lymphoma (NHL) Market Share by Type (2015-2020)
Table 36. North America Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020) (Million US$)
Table 37. North America Non Hodgkin Lymphoma (NHL) Market Share by Application (2015-2020)
Table 38. Europe Key Players Non Hodgkin Lymphoma (NHL) Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Non Hodgkin Lymphoma (NHL) Market Share (2019-2020)
Table 40. Europe Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Non Hodgkin Lymphoma (NHL) Market Share by Type (2015-2020)
Table 42. Europe Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Non Hodgkin Lymphoma (NHL) Market Share by Application (2015-2020)
Table 44. China Key Players Non Hodgkin Lymphoma (NHL) Revenue (2019-2020) (Million US$)
Table 45. China Key Players Non Hodgkin Lymphoma (NHL) Market Share (2019-2020)
Table 46. China Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020) (Million US$)
Table 47. China Non Hodgkin Lymphoma (NHL) Market Share by Type (2015-2020)
Table 48. China Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020) (Million US$)
Table 49. China Non Hodgkin Lymphoma (NHL) Market Share by Application (2015-2020)
Table 50. Japan Key Players Non Hodgkin Lymphoma (NHL) Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Non Hodgkin Lymphoma (NHL) Market Share (2019-2020)
Table 52. Japan Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Non Hodgkin Lymphoma (NHL) Market Share by Type (2015-2020)
Table 54. Japan Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Non Hodgkin Lymphoma (NHL) Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Non Hodgkin Lymphoma (NHL) Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Non Hodgkin Lymphoma (NHL) Market Share (2019-2020)
Table 58. Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Non Hodgkin Lymphoma (NHL) Market Share by Type (2015-2020)
Table 60. Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Non Hodgkin Lymphoma (NHL) Market Share by Application (2015-2020)
Table 62. India Key Players Non Hodgkin Lymphoma (NHL) Revenue (2019-2020) (Million US$)
Table 63. India Key Players Non Hodgkin Lymphoma (NHL) Market Share (2019-2020)
Table 64. India Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020) (Million US$)
Table 65. India Non Hodgkin Lymphoma (NHL) Market Share by Type (2015-2020)
Table 66. India Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020) (Million US$)
Table 67. India Non Hodgkin Lymphoma (NHL) Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Non Hodgkin Lymphoma (NHL) Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Non Hodgkin Lymphoma (NHL) Market Share (2019-2020)
Table 70. Central & South America Non Hodgkin Lymphoma (NHL) Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Non Hodgkin Lymphoma (NHL) Market Share by Type (2015-2020)
Table 72. Central & South America Non Hodgkin Lymphoma (NHL) Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Non Hodgkin Lymphoma (NHL) Market Share by Application (2015-2020)
Table 74. F. Hoffmann-La Roche Company Details
Table 75. F. Hoffmann-La Roche Business Overview
Table 76. F. Hoffmann-La Roche Product
Table 77. F. Hoffmann-La Roche Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020) (Million US$)
Table 78. F. Hoffmann-La Roche Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Product
Table 82. Johnson & Johnson Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020) (Million US$)
Table 83. Johnson & Johnson Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Product
Table 87. Merck Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020) (Million US$)
Table 88. Merck Recent Development
Table 89. Bristol Myers Squibb Company Details
Table 90. Bristol Myers Squibb Business Overview
Table 91. Bristol Myers Squibb Product
Table 92. Bristol Myers Squibb Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020) (Million US$)
Table 93. Bristol Myers Squibb Recent Development
Table 94. Celgene Company Details
Table 95. Celgene Business Overview
Table 96. Celgene Product
Table 97. Celgene Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020) (Million US$)
Table 98. Celgene Recent Development
Table 99. Eli Lilly Company Details
Table 100. Eli Lilly Business Overview
Table 101. Eli Lilly Product
Table 102. Eli Lilly Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020) (Million US$)
Table 103. Eli Lilly Recent Development
Table 104. GlaxoSmithKline Company Details
Table 105. GlaxoSmithKline Business Overview
Table 106. GlaxoSmithKline Product
Table 107. GlaxoSmithKline Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020) (Million US$)
Table 108. GlaxoSmithKline Recent Development
Table 109. Bayer Business Overview
Table 110. Bayer Product
Table 111. Bayer Company Details
Table 112. Bayer Revenue in Non Hodgkin Lymphoma (NHL) Business (2015-2020) (Million US$)
Table 113. Bayer Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non Hodgkin Lymphoma (NHL) Market Share by Type: 2020 VS 2026
Figure 2. Standard Features
Figure 3. Exellent Features
Figure 4. Global Non Hodgkin Lymphoma (NHL) Market Share by Application: 2020 VS 2026
Figure 5. Hosptial Case Studies
Figure 6. Clinic Case Studies
Figure 7. Non Hodgkin Lymphoma (NHL) Report Years Considered
Figure 8. Global Non Hodgkin Lymphoma (NHL) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Non Hodgkin Lymphoma (NHL) Market Share by Regions: 2020 VS 2026
Figure 10. Global Non Hodgkin Lymphoma (NHL) Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Non Hodgkin Lymphoma (NHL) Market Share by Players in 2019
Figure 13. Global Top Non Hodgkin Lymphoma (NHL) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non Hodgkin Lymphoma (NHL) as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Non Hodgkin Lymphoma (NHL) Revenue in 2019
Figure 15. North America Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Non Hodgkin Lymphoma (NHL) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed

以下、関連資料のご紹介

ホジキンリンパ腫治療薬の世界市場（～2026年）

Global Hodgkin's Lymphoma Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY12208 2020年11月25日 97Pages
当調査資料はホジキンリンパ腫治療薬のグローバル市場について調査・分析したレポートです。種類別（アルキル化抗腫瘍剤、抗腫瘍性抗腫瘍剤、抗腫瘍剤ビンカアルカロイド剤、ポドフィロトキシン誘導体抗腫瘍剤、抗タボライト抗腫瘍剤、アントラサイクリン抗腫瘍剤、抗微小管抗腫瘍剤、コルチコステロイド）市場規模、用途別...

リンパ芽球性リンパ腫治療薬の世界市場（～2026年）

Global Lymphoblastic Lymphoma Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY12558 2020年11月25日 97Pages
当調査資料はリンパ芽球性リンパ腫治療薬のグローバル市場について調査・分析したレポートです。種類別（化学療法、幹細胞移植、標的療法、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

悪性リンパ腫の世界市場（～2026年）

Global Malignant Lymphoma Market Size, Status and Forecast 2020-2026
MRC2-11QY12582 2020年11月25日 91Pages
当調査資料は悪性リンパ腫のグローバル市場について調査・分析したレポートです。種類別（リンパ節、骨髄、脾臓、血液、その他の臓器）市場規模、用途別（製薬会社、病院、学術研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド...

濾胞性リンパ腫治療の世界市場（～2026年）

Global Follicular Lymphoma Therapeutic Market Size, Status and Forecast 2020-2026
MRC2-11QY11978 2020年11月25日 99Pages
当調査資料は濾胞性リンパ腫治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、モノクローナル抗体、幹細胞移植）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

バーキットリンパ腫治療薬の世界市場（～2026年）

Global Burkitt Lymphoma Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY11212 2020年11月25日 94Pages
当調査資料はバーキットリンパ腫治療薬のグローバル市場について調査・分析したレポートです。種類別（高度ドレッシング、生物製剤、従来型熱傷治療製品、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...

バーキットリンパ腫治療の世界市場（～2026年）

Global Burkitt Lymphoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11213 2020年11月25日 99Pages
当調査資料はバーキットリンパ腫治療のグローバル市場について調査・分析したレポートです。種類別（ARV-825、アリセルチブ、bb-2121、イブルチニブ、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

成人T細胞白血病/リンパ腫治療の世界市場（～2026年）

Global Adult T-Cell Leukemia/Lymphoma Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13584 2020年11月30日 94Pages
当調査資料は成人T細胞白血病/リンパ腫治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、幹細胞移植、標的療法、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

未分化大細胞リンパ腫治療薬の世界市場（～2026年）

Global Anaplastic Large Cell Lymphoma Therapeutics Market Insights and Forecast to 2026
MRC2-11QY02428 2020年11月20日 113Pages
当調査資料は未分化大細胞リンパ腫治療薬のグローバル市場について調査・分析したレポートです。種類別（AKR-303、AZD-3463、ブレンツキシマブベドチン、CEP-28122、その他）市場規模、用途別（入院患者、外来患者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

びまん性大細胞型B細胞リンパ腫治療薬の世界市場（～2026年）

Global Diffuse Large B Cell Lymphoma Drug Market Insights and Forecast to 2026
MRC2-11QY05214 2020年11月20日 146Pages
当調査資料はびまん性大細胞型B細胞リンパ腫治療薬のグローバル市場について調査・分析したレポートです。種類別（リツキサン、シクロホスファミド、ドキソルビシン、ビンクリスチン、プレドニゾン）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

ドラッグデリバリーシステム（DDS）の世界市場（～2026年）

Global Drug Delivery Systems Market Size, Status and Forecast 2020-2026
MRC2-11QY11715 2020年11月25日 96Pages
当調査資料はドラッグデリバリーシステム（DDS）のグローバル市場について調査・分析したレポートです。種類別（子宮内インプラント、プロドラッグインプラント、ポリマードラッグデリバリー、標的化ドラッグデリバリー）市場規模、用途別（感染症、腫瘍、泌尿器科、糖尿病、中枢神経系）市場規模、地域別（北米、米国、...

ホジキンリンパ腫治療薬の世界市場（～2026年） Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
悪性リンパ腫の世界市場（～2026年） Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have the ability to spread, they are called malignant. The lymphatic system runs throughout our bodies and is composed of lymphoid tissue, vessels, and fluid. Lymphoid tissue contains lymph nodes, which are part…
濾胞性リンパ腫治療の世界市場（～2026年） Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…
バーキットリンパ腫治療薬の世界市場（～2026年） Burn is an injury to skin or any tissue of body due to excessive heat, radiation, radioactivity, electricity, or contact with chemical materials. Burns are a serious problem across the globe and the World Health Organization estimates that it results in more than 265,000 deaths occur annually. Moreo…